ICON Public Limited Company (FRA:IJF)

Germany flag Germany · Delayed Price · Currency is EUR
94.34
-2.56 (-2.64%)
Last updated: Apr 23, 2026, 8:04 AM CET
Market Cap7.52B -33.4%
Revenue (ttm)6.91B -2.5%
Net Income510.93M -19.8%
EPS6.37 -16.8%
Shares Outn/a
PE Ratio14.72
Forward PE9.13
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume7
Open94.34
Previous Close96.90
Day's Range94.34 - 94.34
52-Week Range66.26 - 170.30
Betan/a
RSI51.10
Earnings DateApr 30, 2026

About FRA:IJF

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient... [Read more]

Industry Commercial Physical and Biological Research
Founded 1989
Employees 39,800
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol IJF

Financial Performance

In 2024, FRA:IJF's revenue was $8.28 billion, an increase of 1.99% compared to the previous year's $8.12 billion. Earnings were $791.47 million, an increase of 29.26%.

Financial numbers in USD Financial Statements

News

ICON and Advarra Introduce New ‘Research-Ready,' Connected Site Network Model

DUBLIN & COLUMBIA, Md.--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connect...

4 weeks ago - Business Wire

Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ICON PLC (“ICON” or the “Company”) (NASDAQ:...

5 weeks ago - GlobeNewsWire

Ademi LLP Investigates Claims of Securities Fraud against ICON plc

MILWAUKEE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating possible securities fraud claims against ICON (NASDAQ: ICLR). The investigation results from inaccurate statements ICON may have...

2 months ago - GlobeNewsWire

ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm

LOS ANGELES, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ICON Public Limit...

2 months ago - GlobeNewsWire

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement

(NASDAQ: ICLR) NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating ICON plc (NASDAQ: ICLR) following the company's disclosure on February 12, 2026, that an internal accounti...

2 months ago - PRNewsWire

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues - Hagens Berman

ICLR Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Feb. 13, 2026 /PRNewswire/ -- Investors in ICON plc (NASDAQ: ICLR) saw the price of their shares drop about 49% during tra...

2 months ago - PRNewsWire

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues – Hagens Berman

SAN FRANCISCO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Investors in ICON plc (NASDAQ: ICLR) saw the price of their shares drop about 49% during trading on February 12, 2026, after the company disclosed its ...

2 months ago - GlobeNewsWire

Why this drug-research company's stock is having its worst day since 1999

Shares of Icon were plummeting on Thursday toward their worst day in decades, as the announcement of an accounting probe added to all the pressures the contract research organization sector has alread...

2 months ago - Market Watch

ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether ICON Public Limited Company (NASDAQ: ICLR) or its executive officers complied with the federal securities law...

2 months ago - GlobeNewsWire

ICLR Down 30%: ICON plc Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Shares of ICON fell over 30% after the company disclosed that its Audit Committee is conducting an investigation. Investors should contact Block & Leviton.

2 months ago - GlobeNewsWire

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

DUBLIN--(BUSINESS WIRE)--ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices.

2 months ago - Business Wire

ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Ca...

3 months ago - Business Wire

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech tr...

4 months ago - Business Wire

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites f...

5 months ago - Business Wire

ICON plc to Present at the Jefferies London Healthcare Conference

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Jefferies London Healthcare Conference.

5 months ago - Business Wire

ICON Reports Third Quarter 2025 Results

DUBLIN--(BUSINESS WIRE)--ICON Reports Third Quarter 2025 Results.

6 months ago - Business Wire

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Third Quarter 2025 Earnings Conference Call.

7 months ago - Business Wire

ICON Announces CEO Transition

DUBLIN--(BUSINESS WIRE)--ICON Announces CEO Transition.

8 months ago - Business Wire

ICON plc to Participate at Upcoming Investor Conferences

DUBLIN--(BUSINESS WIRE)--ICON plc to Participate at Upcoming Investor Conferences.

8 months ago - Business Wire

ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery

Clinical research organization ICON plc  ICLR stock is surging on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2025 sales guidance.

9 months ago - Benzinga

ICON Announces Results of Annual General Meeting

DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.

9 months ago - Business Wire

ICON Reports Second Quarter 2025 Results

DUBLIN--(BUSINESS WIRE)--ICON Reports Second Quarter 2025 Results.

9 months ago - Business Wire

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisation...

10 months ago - Business Wire

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awar...

10 months ago - Business Wire

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Second Quarter 2025 Earnings Conference Call.

10 months ago - Business Wire